Jim Rogers, former CEO of Duke and PSI Energy, dies at 71
Rogers’ path to building the nation’s largest electric utility began in 1988, when he took over struggling PSI Energy in Indiana.
John Russell
Articles
Lilly asserts bragging rights over Humira for hot-selling drug Taltz
The Indianapolis drugmaker said its 2-year-old anti-inflammatory medicine showed superiority in a head-to-head trial against Humira, the world’s best-selling drug, for treating psoriatic arthritis.
Nursing homes start facing pinch of penalties for hospital readmissions
The penalties will be as much as 2 percent of Medicare reimbursements, and could be worth millions of dollars to large nursing-home chains with locations spread across Indiana and the nation.
IU Health People Mover train to shut down indefinitely
The health system said the 15-year-old elevated train service needs major maintenance, but did not say whether the system would ever return to service.
BioCrossroads chief Johnson stepping down to lead parent group full time
David Johnson, who has led the life science advocacy and investment group for 14 years, will take over full-time leadership of the Central Indiana Corporate Partnership in 2019.
Entrepreneur finds financial success with deep-tissue therapy
Entrepreneur Michael Arnolt teamed with an inventor more than 20 years ago to launch an enterprise that has sold thousands of steel therapy instruments and trained thousands of clinicians.
Cook Group gets ready for more growth around Indiana
The company is planning to add up to 1,330 jobs over the next eight years, focused mainly on its Regentec division in Indianapolis and its Profile Park in Bloomington, site of a former GE refrigerator factory.
Brazilian ag-tech firm picks Indiana for U.S. HQ, plans 334 jobs
Solinftec said Thursday it would invest $50.6 million to establish operations in the Hoosier state. The company makes technology that helps farmers collect and analyze data to increase crop returns.
Carmel spine surgeon wins $112M verdict in royalty battle with Medtronic
At issue in the five-year legal dispute was whether Dr. Rick Sasso was properly compensated for various inventions, and whether Minnesota-based Medtronic paid him sufficient royalties as spelled out in their agreements.
Riley Children’s Foundation announces $175 million campaign
It’s the foundation’s first capital campaign since 2010, when it raised $200 million. The money will be used for pediatric research, patient care, maternity and newborn health, and family support programs.
IU School of Dentistry searching for new dean
Dr. John Williams, dean since 2010, is stepping down next summer after turning 67, in accordance with university policy. He helped raise more than $70 million and expanded the school’s clinical space by about one-third.
Opioid war rages on, but those on the front lines see progress
The crisis has been years in the making, and the job of wrestling it to the ground has grown into a massive task. No one is yet predicting when the state will be able to declare victory.
Lilly installing new labs, offices, manufacturing lines in $90M project
The project will give the Indianapolis-based pharmaceutical company upgraded lab space as it pushes to launch more drugs for diabetes, cancer, pain and other ailments.
State programs aimed at cutting energy usage aren’t enough, critics say
Indiana, one of the largest per-capita energy consumers in the nation, ranks 40th among states for energy efficiency, according to the American Council for an Energy-Efficient Economy.
Indianapolis Medical Society to move out of headquarters, hold online auction of artifacts
The society, which has lost more than half its membership in the past two decades, is looking for a new home for many historical items, including a 1910 Waltham Gothic revival grandfather hall clock, a painting by Hoosier artist T.C. Steele and historic medical treatment books and documents.
Two IU researchers win $2.3M grant to study neuropathy in cancer patients
The researchers are testing the effectiveness of a small, targeted molecule to prevent or reverse chemotherapy-induced peripheral neuropathy—a nerve problem that causes pain, numbness and tingling.
Endocyte insiders to reap millions from Novartis deal
Executives and directors of the West Lafayette-based biotech hold nearly 9 percent of Endocyte stock, worth about $177 million, based on the deal price of $24 a share.
University researchers make discoveries count as entrepreneurs
A few influential “serial entrepreneurs” in Indiana universities feel an itch to turn their discoveries into products and companies, over and over again.
NCAA, Pentagon, IU medical school broaden concussion research on student-athletes
The NCAA, which has been sued dozens of times for its role in handling concussions, will help fund an expanded $22.5 million study to examine the impacts of head injuries.
Tobacco, opioid epidemics claimed 14,200 Hoosier lives in 2017, studies say
Two reports, sponsored by the Richard M. Fairbanks Foundation, say the state should not let up in fighting twin scourges that claim thousands of lives and cost billions of dollars in health care costs and lost productivity.